PATENT CLAIM ANALYSIS

Application Number: 15748214
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "252190"]

Abstract:
Described are cancer therapies and anti-cancer compounds. In particular, disclosed are inhibitors of ACK1 tyrosine kinase and their use in the treatment of cancer. Methods of screening for new ACK1 tyrosine kinase inhibitors are also disclosed. In specific example, compound having Formula I are disclosed.

Claim (Index 4):
The compound of  claim 1 , wherein R 2  is 4-morpholinyl, 4-piperazinyl, 1-piperidinyl, or 4-piperadinyl group that is unsubstituted or substituted with R 6 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.54545
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15808421', '14910486', '15619671', '14633360', '14204076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8000601223364707
- 35 USC 102 Novelty (BERT): 0.6152272790577684
- Combined Prediction Score: 0.7815768380086006
- Mean Citation Score: 393.75385
- Max Citation Score: 558.143
- Similarity Product: 510.1485097795726

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test